Cidofovir

Cidofovir is a medicine used to treat certain types of infections caused by viruses like Cytomegalovirus (CMV) and Herpes. It works by stopping the viruses from copying their genetic material. It's often given through an IV line into a vein.

Brand names:Vistide
Medication

What people taking Cidofovir report

Every report comes from a Lived member, sent anonymously.

Have you tried Cidofovir for CMV Retinitis?

NameHow it went

About Cidofovir

What It's For

Cidofovir is a prescription antiviral medicine given through a vein (intravenously) to treat cytomegalovirus (CMV) retinitis in people with AIDS. CMV is a common virus in the herpes family that usually stays inactive in the body. When the immune system is severely weakened, it can infect the retina, the light-sensing layer at the back of the eye, and gradually destroy it. Without treatment, CMV retinitis can cause blindness. The original brand, Vistide, is no longer sold in the US, and cidofovir is now available as a generic injection. Because its kidney risks are significant, it is chosen with care. Ganciclovir is the antiviral used most often for CMV retinitis, and cidofovir is one of the alternatives. Restoring the immune system with HIV treatment (antiretroviral therapy) also matters: people on HIV treatment have a lower chance of the eye inflammation coming back. The FDA approval covers only CMV retinitis in people with AIDS. Specialists sometimes use cidofovir off label for other serious viral infections in people with weakened immune systems, most often adenovirus infections after a transplant. Results in those situations vary, and the same kidney risks apply.

How It Works

Viruses such as CMV multiply by copying their genetic material (DNA) inside the cells they infect, using a viral enzyme called DNA polymerase. Inside cells, cidofovir is converted into an active form that blocks the virus's DNA polymerase far more strongly than the body's own versions of that enzyme. Slowing the virus's copying limits further damage to the retina. It does not repair retina that has already been damaged, and it does not clear the virus from the body. The kidneys remove cidofovir from the blood, and cells in the kidney's small tubules actively pull the drug in, which is where it can cause injury. Probenecid, a tablet taken with every dose, blocks that uptake, and IV fluids help flush the drug through. That is why both always accompany cidofovir.

Dosage & Administration

Cidofovir is given by a nurse as a one-hour IV infusion in a clinic or hospital. Treatment begins with an induction phase of one dose a week for two weeks, then continues as maintenance with one dose every two weeks. The dose is based on body weight and is lowered, paused or stopped if kidney tests change. Each infusion day follows a set routine meant to protect the kidneys. Probenecid tablets are taken by mouth three hours before the infusion and again two and eight hours after it ends. At least one liter of saline (salt-water) fluid is given through the IV just before the infusion, and people who can handle the extra fluid receive a second liter during or after it. Completing the full probenecid schedule matters, because it is part of the protection. Eating before each probenecid dose, and taking an anti-nausea medicine if one is prescribed, can reduce nausea. Blood and urine tests of kidney function are done within 48 hours before every dose, along with a white blood cell count. Cidofovir is not started if kidney function is already reduced or there is significant protein in the urine.

Side Effects

Nausea, vomiting, headache, fever and chills are common around infusion days, and many of these come from probenecid rather than cidofovir. Allergic reactions to probenecid usually show up as rash, fever or chills, and in some cases can be a severe whole-body reaction (anaphylaxis); an antihistamine or acetaminophen is sometimes used to prevent or ease milder reactions. Hair loss, loss of appetite, diarrhea and sores in the mouth can also occur. Kidney damage is the main serious risk. In clinical trials, more than half of people on the standard maintenance dose developed signs of kidney injury, such as protein in the urine or a rise in creatinine (a waste product the kidneys normally clear). Kidney failure requiring dialysis, sometimes fatal, has occurred after as few as one or two doses, and kidney function does not always recover after the drug is stopped. Protein in the urine can be an early warning sign, which is why the tests before each dose are not optional. Cidofovir can lower the number of neutrophils, the white blood cells that fight bacterial infection; about a quarter of trial patients had a severe drop. Fever, chills, cough, shortness of breath or unusually pale skin should be reported to the care team right away. It can also cause inflammation inside the front of the eye (uveitis or iritis), seen in about 1 in 10 people in trials, and can lower the pressure inside the eye, occasionally with a loss of sharpness of vision. Eye pain or redness, new sensitivity to light or blurred vision should be reported to the care team right away rather than left until the next eye appointment.

Interactions & Warnings

Because the kidneys bear most of cidofovir's risk, it must not be combined with other medicines that can harm the kidneys. These include IV aminoglycoside antibiotics (such as gentamicin, tobramycin and amikacin), the antifungal amphotericin B, the antiviral foscarnet, IV pentamidine (an anti-infective medicine), the antibiotic vancomycin, and nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen, including over-the-counter versions. These must be stopped at least seven days before cidofovir starts. People who have taken foscarnet in the past have a higher risk of kidney damage and are watched more closely. Probenecid changes how the body clears many other drugs, including acetaminophen, acyclovir, some blood pressure medicines and water pills, and methotrexate, so every medicine and supplement should be reviewed before treatment. HIV treatment can usually continue, but zidovudine (AZT, an older HIV medicine) is paused or taken at half the dose on infusion days only, because probenecid slows its removal. Cidofovir is not used in people who have had a severe allergic reaction to probenecid or other sulfa-containing medicines. In animal studies, cidofovir caused birth defects, tumors and reduced sperm production, so it is treated as a possible cancer-causing agent in humans and is avoided during pregnancy and breastfeeding. Women who could become pregnant should use effective birth control during treatment and for one month afterward. Men should use a barrier method such as condoms during treatment and for three months afterward. Possible effects on fertility are worth discussing before treatment begins.

What to Expect

Cidofovir controls CMV retinitis rather than curing it. In an early trial, people who started cidofovir right away went a median of about four months before their retinitis worsened, compared with about three weeks for people who delayed treatment, although few people stayed on the drug that long. Retinitis can still progress during or after treatment, and CMV can affect other parts of the body, so regular exams with an eye specialist continue throughout. Infusion days take several hours: tablets three hours ahead, IV fluids, the one-hour infusion, and more probenecid later in the day. Dose reductions or pauses because of kidney test changes are common. Side effects often change the plan; in trials, about 4 in 10 people on maintenance treatment stopped cidofovir because of them. How long treatment continues depends on how the eye responds. If the retinitis keeps progressing or returns during treatment, the team may consider whether the virus has become resistant and whether a different antiviral would work better.

Questions to Ask Your Doctor

  1. 1.Why is cidofovir a better fit for me than ganciclovir or another antiviral?
  2. 2.How will we track my kidney function, and what results would lead us to lower the dose or stop?
  3. 3.Which of my current medicines, including over-the-counter pain relievers, need to stop or change before treatment begins?
  4. 4.How often will I see the eye specialist, and which eye symptoms should make me call between visits?
  5. 5.What should I know about fertility, birth control and pregnancy during treatment and afterward?

Last reviewed • Oct 2026

Educational content, not medical advice.